Keywords:
Performed at one institution, Observational, Retrospective, Multidisciplinary cancer care, Calcifications / Calculi, Vacuum assisted biopsy, Surgery, Biopsy, Ultrasound, Mammography, Management, Breast
Authors:
J. Chalfant1, B. Li2, T. Chan1; 1Los Angeles/US, 2Santa Monica/US
DOI:
10.26044/ecr2020/C-13887
Methods and materials
This institutional review board approved HIPAA compliant retrospective study identified 766 cases of high-risk lesions within our institution’s mammography information system (Magview, Burtonsville, MD) from 1/31/2017 to 9/1/2019, 188 of which demonstrated ADH on stereotactic-guided or ultrasound-guided core needle biopsy.
Patients who had concurrent biopsy-proven ipsilateral (17 cases, 9.0%) or contralateral (7 cases, 3.7%) breast malignancy were excluded. Those without a surgical excision pathology report (48 cases, 25.5%) were also excluded; of those lacking surgical pathology reports, 19 did not undergo surgical consultation within our health system, 18 underwent surgical consultation but did not proceed to surgery, and 11 were within 6 months of core needle biopsy.
A total of 113 patients with 116 core needle biopsies demonstrating ADH were included (61.7%). Imaging and pathology reports were reviewed to extract mammographic and sonographic imaging features, biopsy parameters, and patient demographics.